↓ Skip to main content

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Overview of attention for article published in Journal for Immunotherapy of Cancer, July 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 3,487)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
16 news outlets
blogs
1 blog
twitter
60 X users
facebook
1 Facebook page

Citations

dimensions_citation
446 Dimensions

Readers on

mendeley
349 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Published in
Journal for Immunotherapy of Cancer, July 2019
DOI 10.1186/s40425-019-0662-5
Pubmed ID
Authors

Ezra E. W. Cohen, R. Bryan Bell, Carlo B. Bifulco, Barbara Burtness, Maura L. Gillison, Kevin J. Harrington, Quynh-Thu Le, Nancy Y. Lee, Rom Leidner, Rebecca L. Lewis, Lisa Licitra, Hisham Mehanna, Loren K. Mell, Adam Raben, Andrew G. Sikora, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg, Robert L. Ferris

X Demographics

X Demographics

The data shown below were collected from the profiles of 60 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 349 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 349 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 10%
Other 32 9%
Student > Ph. D. Student 32 9%
Student > Bachelor 29 8%
Student > Doctoral Student 21 6%
Other 57 16%
Unknown 143 41%
Readers by discipline Count As %
Medicine and Dentistry 107 31%
Biochemistry, Genetics and Molecular Biology 31 9%
Agricultural and Biological Sciences 16 5%
Immunology and Microbiology 10 3%
Pharmacology, Toxicology and Pharmaceutical Science 8 2%
Other 24 7%
Unknown 153 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 160. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2023.
All research outputs
#259,971
of 26,017,215 outputs
Outputs from Journal for Immunotherapy of Cancer
#47
of 3,487 outputs
Outputs of similar age
#4,994
of 363,159 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 89 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,487 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,159 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.